Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
Add more filters










Publication year range
1.
Transplant Proc ; 50(6): 1710-1714, 2018.
Article in English | MEDLINE | ID: mdl-30056887

ABSTRACT

INTRODUCTION: Because nearly 30,000 people worldwide become living kidney donors each year, donor safety is of the utmost importance. Recent studies have shown that living kidney donation is associated with an increased relative risk for end-stage renal disease (ESRD). It is essential to determine which donors will be more likely to develop ESRD. One of the risk factors for ESRD in living kidney donors is hypertension and, because there are studies demonstrating that low birthweight is a risk factor for developing hypertension in adult life, we hypothesized that donors with low birthweight may be at higher risk of developing renal disease after donation. METHODS: Seventy-three living kidney donors were examined. Donors were divided into 2 cohorts: a group with low birthweight and group with normal birthweight. We checked whether the donor birthweight has an impact on the outcome of donor renal function and on the development of hypertension. RESULTS: Hypertension was observed statistically more frequent in the group with low birthweight (P = .003). CONCLUSION: Glomerular filtration rate before kidney donation was found to be lower in the low-birthweight group.


Subject(s)
Hypertension/etiology , Infant, Low Birth Weight , Kidney Failure, Chronic/etiology , Living Donors , Nephrectomy/adverse effects , Postoperative Complications/etiology , Tissue and Organ Harvesting/adverse effects , Adult , Female , Glomerular Filtration Rate , Humans , Kidney/physiopathology , Kidney Transplantation/adverse effects , Male , Middle Aged , Risk Factors
2.
Am J Transplant ; 17(4): 1042-1049, 2017 04.
Article in English | MEDLINE | ID: mdl-27696662

ABSTRACT

Delayed graft function is a frequent complication following deceased donor renal transplantation, and is closely related to ischemia-reperfusion injury. Experimental and clinical studies have shown protection by remote ischemic conditioning (RIC). We hypothesized that recipient RIC before kidney graft reperfusion reduces the time to graft recovery. This multicenter, blinded, randomized, controlled clinical trial included 225 adult recipients of renal transplants from deceased donors at four transplantation centers in Denmark, Sweden, and the Netherlands. Participants were randomized 1:1 to RIC or sham-RIC. RIC consisted of 4 × 5-min thigh occlusion by an inflatable tourniquet each followed by 5-min deflation, performed during surgery prior to graft reperfusion. The tourniquet remained deflated for sham-RIC. The primary endpoint was the estimated time to a 50% decrease in baseline plasma creatinine (tCr50) calculated from plasma creatinine measurements 30 days posttransplant or 30 days after the last, posttransplant dialysis. No significant differences were observed between RIC and sham-RIC-treated patients in the primary outcome median tCr50 (122 h [95% confidence interval [CI] 98-151] vs. 112 h [95% CI 91-139], p = 0.58), or the number of patients receiving dialysis in the first posttransplant week (33% vs. 35%, p = 0.71). Recipient RIC does not reduce the time to graft recovery in kidney transplantation from deceased donors. ClinicalTrials.gov: NCT01395719.


Subject(s)
Delayed Graft Function/prevention & control , Ischemic Preconditioning/methods , Kidney Transplantation , Reperfusion Injury/prevention & control , Tissue Donors , Adult , Aged , Death , Female , Graft Survival , Humans , Kidney Function Tests , Male , Middle Aged , Netherlands
3.
J Transl Med ; 14: 20, 2016 Jan 20.
Article in English | MEDLINE | ID: mdl-26791565

ABSTRACT

Kidney transplantation is the treatment of choice in patients with end stage renal disease. During kidney transplantation ischemia reperfusion injury (IRI) occurs, which is a risk factor for acute kidney injury, delayed graft function and acute and chronic rejection. Kidneys from living donors show a superior short- and long-term graft survival compared with deceased donors. However, the shortage of donor kidneys has resulted in expansion of the donor pool by using not only living- and brain death donors but also kidneys from donation after circulatory death and from extended criteria donors. These grafts are associated with an increased sensitivity to IRI and decreased graft outcome due to prolonged ischemia and donor comorbidity. Therefore, preventing or ameliorating IRI may improve graft survival. Animal experiments focus on understanding the mechanism behind IRI and try to find methods to minimize IRI either before, during or after ischemia. This review evaluates the different experimental strategies that have been investigated to prevent or ameliorate renal IRI. In addition, we review the current state of translation to the clinical setting. Experimental research has contributed to the development of strategies to prevent or ameliorate IRI, but promising results in animal studies have not yet been successfully translated to clinical use.


Subject(s)
Ischemia/therapy , Kidney Transplantation , Kidney/blood supply , Reperfusion Injury/therapy , Translational Research, Biomedical , Animals , Humans , Kidney/pathology , Treatment Outcome
4.
Br J Surg ; 103(2): e62-72, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26662845

ABSTRACT

BACKGROUND: Transplant surgery is facing a shortage of deceased donor organs. In response, the criteria for organ donation have been extended, and an increasing number of organs from older donors are being used. For recipients, the benefits of transplantation are great, and the growing ageing population has led to increasing numbers of elderly patients being accepted for transplantation. METHODS: The literature was reviewed to investigate the impact of age of donors and recipients in abdominal organ transplantation, and to highlight aspects of the fine balance in donor and recipient selection and screening, as well as allocation policies fair to young and old alike. RESULTS: Overall, kidney and liver transplantation from older deceased donors have good outcomes, but are not as good as those from younger donors. Careful donor selection based on risk indices, and potentially biomarkers, special allocation schemes to match elderly donors with elderly recipients, and vigorous recipient selection, allows good outcomes with increasing age of both donors and recipients. The results of live kidney donation have been excellent for donor and recipient, and there is a trend towards inclusion of older donors. Future strategies, including personalized immunosuppression for older recipients as well as machine preservation and reconditioning of donor organs, are promising ways to improve the outcome of transplantation between older donors and older recipients. CONCLUSION: Kidney and liver transplantation in the elderly is a clinical reality. Outcomes are good, but can be optimized by using strategies that modify donor risk factors and recipient co-morbidities, and personalized approaches to organ allocation and immunosuppression.


Subject(s)
Kidney Transplantation/methods , Liver Transplantation/methods , Aged , Forecasting , Humans , Immunosuppression Therapy/methods , Kidney Transplantation/ethics , Liver Transplantation/ethics , Living Donors/ethics , Living Donors/statistics & numerical data , Living Donors/supply & distribution , Prognosis , Tissue Donors/statistics & numerical data , Tissue Donors/supply & distribution , Tissue and Organ Procurement/statistics & numerical data
5.
Am J Transplant ; 15(11): 2947-54, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26153103

ABSTRACT

The aim of this study is to review the surgical outcome of kidney retransplantation in the ipsilateral iliac fossa in comparison to first kidney transplants. The database was screened for retransplantations between 1995 and 2013. Each study patient was matched with 3 patients with a first kidney transplantation. Just for graft and patient survival analyses, we added an extra control group including all patients receiving a second transplantation in the contralateral iliac fossa. We identified 99 patients who received a retransplantation in the ipsilateral iliac fossa. There was significantly more blood loss and longer operative time in the retransplantation group. The rate of vascular complications and graft nephrectomies within 1 year was significantly higher in the study group. The graft survival rates at 1 year and 3, 5, and 10 years were 76%, 67%, 61%, and 47% in the study group versus 94%, 88%, 77%, and 67% (p < 0.001) in the first control group versus 91%, 86%, 78%, and 57% (p = 0.008) in the second control group. Patient survival did not differ significantly between the groups. Kidney retransplantation in ipsilateral iliac fossa is surgically challenging and associated with more vascular complications and graft loss within the first year after transplantation. Whenever feasible, the second renal transplant (first retransplant) should be performed contralateral to the prior failed one.


Subject(s)
Kidney Transplantation/adverse effects , Nephrectomy/methods , Replantation/methods , Academic Medical Centers , Adult , Case-Control Studies , Female , Follow-Up Studies , Graft Rejection , Graft Survival , Humans , Kaplan-Meier Estimate , Kidney Transplantation/methods , Male , Middle Aged , Netherlands , Operative Time , Proportional Hazards Models , Reoperation/methods , Replantation/adverse effects , Retrospective Studies , Risk Assessment , Statistics, Nonparametric , Survival Rate , Time Factors , Treatment Outcome
6.
Am J Transplant ; 15(6): 1701-7, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25833120

ABSTRACT

In 2006, a survey from the American Society of Transplant Surgeons disclosed significant and sometimes fatal hemorrhagic events in live donor nephrectomies (LDN) related to failure of clips, leading to the contraindication of the Weck® Hem-o-lok® clip for control of the renal artery during LDN. A survey regarding vascular control techniques, their perceived safety ratings and their failures was sent to 645 European Society for Organ Transplantation members who profiled their profession as "surgeon" and selected "kidney" as organ type. Two hundred forty-three (41%) members responded, of whom 171 (63.3%) independently perform LDN. Their responses were analyzed. For arterial and venous vascular control, the GIA™ and TA™stapler are used most frequently, and were rated the safest. Of the 121 reported hemorrhagic events, slippage and dislodgement of clips occurred at least 58 times, while stapler malfunction occurred at least 40 times. One donor death from hemorrhage related to clip dysfunction was reported. Hemorrhagic complications of LDN with fatal and non-fatal outcomes still occur. Strikingly, many surgeons do not use the vascular closing technique that they consider most safe. Failure of non-transfixion techniques is associated with greater risks for the donor. Control of major vessels in LDN must employ transfixion techniques for optimal donor safety.


Subject(s)
Blood Loss, Surgical/prevention & control , Kidney Transplantation , Kidney/surgery , Living Donors , Nephrectomy/methods , Surgeons/statistics & numerical data , Surveys and Questionnaires , Adult , Female , Humans , Kidney/blood supply , Male , Middle Aged , Online Systems , Patient Safety , Risk Factors , Surgical Instruments/adverse effects , Surgical Staplers/adverse effects , Sutures/adverse effects
7.
Am J Transplant ; 8(12): 2516-26, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19032222

ABSTRACT

The use of alpha1,3-galactosyltransferase gene-knockout (GalT-KO) swine donors in discordant xenotransplantation has extended the survival of cardiac xenografts in baboons following transplantation. Eight baboons received heterotopic cardiac xenografts from GalT-KO swine and were treated with a chronic immunosuppressive regimen. The pathologic features of acute humoral xenograft rejection (AHXR), acute cellular xenograft rejection (ACXR) and chronic rejection were assessed in the grafts. No hyperacute rejection developed and one graft survived up to 6 months after transplantation. However, all GalT-KO heart grafts underwent graft failure with AHXR, ACXR and/or chronic rejection. AHXR was characterized by interstitial hemorrhage and multiple thrombi in vessels of various sizes. ACXR was characterized by TUNEL(+) graft cell injury with the infiltration of T cells (including CD3 and TIA-1(+) cytotoxic T cells), CD4(+) cells, CD8(+) cells, macrophages and a small number of B and NK cells. Chronic xenograft vasculopathy, a manifestation of chronic rejection, was characterized by arterial intimal thickening with TUNEL(+) dead cells, antibody and complement deposition, and/or cytotoxic T-cell infiltration. In conclusion, despite the absence of the Gal epitope, acute and chronic antibody and cell-mediated rejection developed in grafts, maintained by chronic immunosupression, presumably due to de novo responses to non-Gal antigens.


Subject(s)
Galactosyltransferases/genetics , Galactosyltransferases/physiology , Graft Rejection/immunology , Heart Transplantation/immunology , Papio hamadryas/immunology , Swine, Miniature/immunology , Transplantation, Heterologous/immunology , Animals , Animals, Genetically Modified , Antibody Formation/physiology , CD4-Positive T-Lymphocytes/pathology , CD8-Positive T-Lymphocytes/pathology , Graft Rejection/pathology , Graft Rejection/physiopathology , Heart Transplantation/pathology , Heart Transplantation/physiology , Immunity, Cellular/physiology , Immunoglobulin G/blood , Immunoglobulin M/blood , Killer Cells, Natural/pathology , Swine , Swine, Miniature/genetics , Thrombosis/pathology , Transplantation, Heterologous/pathology , Transplantation, Heterologous/physiology , Troponin T/blood
8.
Transplant Proc ; 40(2): 543-6, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18374124

ABSTRACT

BACKGROUND: To avoid hyperacute rejection of xeno-organs, alpha1,3-galactosyltransferase knock-out (GalT-KO) pigs have been produced. However, Galalpha1,3Gal (Gal) determinant elimination may expose cryptic carbohydrate antigens and/or generate new antigens that might interfere with the human immune response. METHODS: Glycolipids isolated from small intestine and pancreas of two GalT-KO and one wild-type (WT) pig were tested for immune reactivity with antibodies on thin-layer chromatograms after separation by high-performance liquid chromatography, and selected fractions were analysed by proton NMR spectroscopy. RESULTS: Immunostaining using purified human anti-Gal Abs revealed that tissues from WT animals express large amounts of Gal-antigens whereas GalT-KO tissues lacked these antigens. Proton NMR spectroscopy on small intestine fractions revealed both linear and branched nona- and decaglycosylceramides, respectively, with terminal Gal-epitopes. In corresponding GalT-KO fractions, Gal-epitopes seemed to be replaced by terminal alpha1,2fucoses. Two novel branched blood group H compounds was found in the GalT-KO intestine. CONCLUSIONS: The structural complexity of alphaGal-terminating antigens in the WT organs is very high. Knockout of alpha1,3GalT by gene-targeting results in elimination of Gal-determinants. In addition structurally novel alpha1,2fucose-terminated blood group H compounds were identified in the GalT-KO tissue. These compounds are not expected to be recognized by the human immune system.


Subject(s)
ABO Blood-Group System/genetics , Galactosyltransferases/deficiency , Glycolipids/metabolism , Intestine, Small/metabolism , Organisms, Genetically Modified , Pancreas/metabolism , Animals , Antigens/genetics , Galactose/genetics , Galactosyltransferases/genetics , Humans , Intestine, Small/enzymology , Swine/genetics , Swine, Miniature/genetics , Transplantation, Heterologous
9.
Cells Tissues Organs ; 180(4): 195-203, 2005.
Article in English | MEDLINE | ID: mdl-16330876

ABSTRACT

The adult spleen is a source of early hematopoietic stem cells (HSC). We therefore studied whether culturing spleen or bone marrow (BM) HSC in medium containing 5-azacytidine could induce a cardiac phenotype. c-kit enrichment and depletion of adult pig spleen and BM mononuclear cells were obtained by magnetic bead separation using biotinylated pig stem cell factor (c-kit ligand). Cells were incubated with 5-azacytidine for 24 h and refreshed with 5-azacytidine-free medium every 48 h. Western blot was used to detect cardiac troponin and myosin heavy chains. Although 5-azacytidine treatment led to the formation of ball-like cell clusters in both c-kit-enriched populations, these clusters showed no rhythmic contractions (beating), as observed by others. Furthermore, neither cardiac troponin nor myosin was detected in cells derived from either source. Our methodology and treatment with 5-azacytidine did not induce cardiac gene expression in porcine HSC derived from either pig spleen or BM.


Subject(s)
Azacitidine/pharmacology , Bone Marrow Cells/drug effects , Bone Marrow Cells/metabolism , Myocardium/cytology , Proto-Oncogene Proteins c-kit/metabolism , Spleen/drug effects , Spleen/metabolism , Animals , Blotting, Western , Bone Marrow Cells/cytology , Cell Differentiation/drug effects , Cells, Cultured , Hematopoiesis , Immunomagnetic Separation , Myosins/deficiency , Proto-Oncogene Proteins c-kit/genetics , Spleen/cytology , Swine , Troponin I/deficiency
11.
Transplant Proc ; 37(1): 489-90, 2005.
Article in English | MEDLINE | ID: mdl-15808685

ABSTRACT

Hearts from alpha1,3-Galactosyltransferase gene-knockout (GaIT-KO) pigs were transplanted heterotopically into 8 baboons that received an anti-CD154 monoclonal antibody (mAb)-based immunosuppressive regimen and heparin. Three baboons died or were euthanized with beating grafts on 16, 23, and 56 days, respectively, and the remaining 5 grafts functioned for 59-179 days. Hyperacute rejection did not occur, and classical features of acute humoral xenograft or acute cellular rejection were rare. However, thrombotic microangiopathy (TM) developed in all cases; its onset was delayed in 2 baboons that received aspirin. Function of a pig organ in a baboon for a period approaching 6 months has not been reported previously and lends encouragement that the barriers to xenotransplantation will be overcome, but TM requires investigation.


Subject(s)
Aspirin/therapeutic use , Fibrinolytic Agents/therapeutic use , Galactosyltransferases/deficiency , Galactosyltransferases/genetics , Gene Deletion , Graft Rejection/prevention & control , Heart Transplantation/methods , Thrombosis/prevention & control , Transplantation, Heterologous/methods , Animals , Graft Survival , Papio , Swine
12.
J Heart Lung Transplant ; 24(1): 92-4, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15653386

ABSTRACT

Troponin T levels have been monitored in baboons (n = 8) undergoing pig heterotopic heart transplantation, and correlated with a decrease in graft contractions and graft survival. Pig heart graft survival was from 12 to 139 days (mean 45, median 33), and graft failure was associated with predominant thrombotic microangiopathy and ischemia, with focal hemorrhage, and edema. An increase in troponin T levels 5 to 6 days before graft failure correlated closely with diminished graft contractions. An increase in troponin T was a reliable indicator that graft dysfunction was occurring.


Subject(s)
Heart Transplantation , Transplantation, Heterotopic , Troponin T/metabolism , Animals , Biomarkers/blood , Cold Ischemia , Graft Survival/physiology , Models, Cardiovascular , Myocardial Ischemia/etiology , Myocardial Ischemia/metabolism , Myocardial Ischemia/physiopathology , Papio , Swine
13.
Xenotransplantation ; 11(4): 361-70, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15196131

ABSTRACT

BACKGROUND: Successful hematopoietic cell allotransplantation results in donor-specific tolerance, but this approach has been unsuccessful in the wild-type pig-to-baboon xenotransplantation model, as pig cells were lost from the circulation within 5 days. However, after cessation of immunosuppressive therapy on day 28, all baboons demonstrated non-specific unresponsiveness on mixed leukocyte reaction (MLR) for at least 30 days. We have now investigated the transplantation of bone marrow (BM) cells from miniature swine homozygous for alpha1,3-galactosyltransferase gene-knockout (GalT-KO). METHODS: Baboons (n = 3) were pre-treated with whole body and thymic irradiation, anti-thymocyte globulin, and splenectomy, and received immunosuppressive and supportive therapy for 28 days. BM was harvested from GalT-KO swine (n = 3). The baboons were monitored for the presence of pig cells by flow cytometry and colony-forming units (CFUs), and for cellular reactivity by MLR. RESULTS: A mean of 11 x 10(8) BM cells/kg was infused into each baboon. The mean absolute numbers and percentages of pig cells detected in the blood at 2 h and on days 1, 2 and 4, respectively, were 641/microl (9.5%), 132/microl (3.4%), 242/microl (3.9%), and 156/microl (2.9%). One baboon died (from accidental hemorrhage) on day 6, at which time chimerism was present in the blood (2.0%) and BM (6.4%); pig cell engraftment in the BM was confirmed by polymerase chain reaction (PCR) of CFUs. In the two other baboons, blood chimerism was lost after day 5 but returned at low levels (<1%) between days 9 to 16 and 7 to 17, respectively, indicating transient BM engraftment. Both surviving baboons showed non-specific unresponsiveness on MLR until they were euthanized on days 85 and 110, respectively. CONCLUSIONS: By using BM cells from GalT-KO pigs, chimerism was detected at levels comparable with previous studies when 30-fold more growth factor-mobilized peripheral blood progenitor cells had been transplanted. In addition, cellular hyporesponsiveness was prolonged. However, long-term engraftment and chimerism were not achieved.


Subject(s)
Bone Marrow Transplantation , Galactosyltransferases/deficiency , Galactosyltransferases/genetics , Gene Deletion , Papio , Swine , Animals , Animals, Genetically Modified , Antibodies/immunology , Bone Marrow/immunology , Bone Marrow Transplantation/immunology , Chimerism , Galactosyltransferases/immunology , Leukocytes/immunology , Lymphocyte Culture Test, Mixed , Papio/immunology , Polymerase Chain Reaction , Swine/genetics , Transplantation Conditioning , Transplantation, Heterologous
17.
Xenotransplantation ; 11(1): 27-32, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14962290

ABSTRACT

AIM: to study whether sensitization to pig antigens results in humoral and/or cellular sensitization to alloantigens in baboons, and thus increases the risks of organ allotransplantation after xenotransplantation. Serum from baboons that were naive (n = 4), sensitized to Gal alpha 1,3Gal (Gal) antigens (n = 2), or sensitized to Gal + non-Gal pig antigens (n = 2) were tested by flow cytometry for the presence of immunoglobulin G (IgG) and IgM antibodies that bind to pig or baboon peripheral blood mononuclear cells (PBMC). Two allosensitized baboons were used as positive controls. The same 10 sera were tested in a complement-mediated cytotoxicity assay to detect cytotoxic antibodies against pig, allo and self-PBMC. The T-cell responses of the same baboons to allogeneic and pig PBMC stimulators in mixed lymphocyte reaction (MLR) were studied. All baboon sera contained cytotoxic antibodies that bound to pig PBMC. Binding and cytotoxicity were higher in xenosensitized baboons, particularly in those sensitized to Gal + non-Gal antigens (P < 0.001). None of the naive or xenosensitized baboon sera bound to baboon PBMC. Serum from allosensitized baboons showed anti-baboon IgG and IgM binding, but there was no increase in binding to pig PBMC or in cytotoxicity to pig cells. The MLR response to pig stimulators in baboons sensitized to non-Gal pig antigens was greater than that of naive or Gal-sensitized baboons (P < 0.001), but there was no increase in the response to baboon cells. In baboons, no in vitro evidence that a previous pig xenograft might endanger the outcome of a subsequent allograft was documented.


Subject(s)
Immunity, Cellular , Immunization , Isoantigens/immunology , Papio/immunology , Swine/immunology , Animals , Antibodies/blood , Antibodies/immunology , Antibody Formation , Cross Reactions , Disaccharides/immunology , Lymphocyte Culture Test, Mixed , Monocytes/immunology
18.
Xenotransplantation ; 11(1): 101-6, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14962299

ABSTRACT

Gal alpha 1,3Gal (Gal) is the first target in antibody-mediated rejection of pig-to-non-human primate xenograft. Its expression may vary between organs and constituents of organs. Gal expression was studied in pancreas, testis, spleen and thymus of 22 pigs, with ages ranging from 1 to 22 months. The immunoperoxidase technique using the biotinylated lectin, Griffonia simplicifolia (IB4), was used. In the pancreas, neither endocrine (islet cells) nor exocrine cells expressed Gal. The Sertoli cells in the testis were negative. The spleen capsule and trabeculae did not stain for Gal, although both splenic T and B lymphocytes expressed Gal (B > T). Thymocytes were weakly positive, whereas thymic epithelial cells were negative for Gal. No age-related differences were seen in any tissues. Porcine islets of Langerhans, Sertoli cells, and the splenic and thymic structural frameworks did not express Gal, and therefore, should be relatively resistant to anti-Gal antibody-mediated rejection. The availability of pigs deficient in Gal as a source of islets may therefore not be beneficial in extending islet graft survival in non-human primate models.


Subject(s)
Disaccharides/analysis , Islets of Langerhans/chemistry , Spleen/chemistry , Swine/metabolism , Testis/chemistry , Thymus Gland/chemistry , Animals , B-Lymphocytes/chemistry , Epithelial Cells/chemistry , Immunoenzyme Techniques , Male , Plant Lectins , Sertoli Cells/chemistry , Spleen/cytology , T-Lymphocytes/chemistry , Testis/cytology , Thymus Gland/cytology
19.
Transplantation ; 75(11): 1799-806, 2003 Jun 15.
Article in English | MEDLINE | ID: mdl-12811237

ABSTRACT

BACKGROUND: Spleen transplantation (Tx) between some strains of rodents can lead to donor-specific tolerance either spontaneously or after a short course of immunosuppression. This study developed a surgical technique for spleen Tx in miniature swine to investigate its immunologic impact in a large animal model. METHODS: The preferred surgical technique of spleen Tx (n=8) involved excision of the donor spleen with its vascular pedicle to the aorta and portal vein. Carrel patches of donor aorta and portal vein were anastomosed to the abdominal aorta and inferior vena cava, respectively, of the (splenectomized) recipient. The results in four major histocompatibility complex-matched pairs that were mismatched for the porcine allelic antigen are reported. Two recipients were untreated, one received a 12-day course of cyclosporine A (CsA) alone, and one received thymic irradiation (700 cGy) and CsA. Hematopoietic cell chimerism was followed by fluorescence-activated cell sorter, and graft survival was assessed by histology. RESULTS: Spleen Tx was technically successful. In two untreated pigs, chimerism was detected in the blood (maximum 5% for 17 and 25 days) and lymph nodes (maximum 6% for 28 and 56 days), but both grafts showed histologic rejection by day 28. In two treated pigs, chimerism was present in the blood for 47 and 57 days, and rejection was prevented, with follow-up for 57 and 217 days, respectively. CONCLUSION: Spleen Tx in major histocompatibility complex-matched pairs treated with CsA+/-thymic irradiation results in prolonged chimerism and is associated with the development of in vivo unresponsiveness to the transplanted spleen.


Subject(s)
Major Histocompatibility Complex/immunology , Spleen/transplantation , Splenectomy/methods , Animals , Biopsy , Cyclosporine/pharmacology , Flow Cytometry , Graft Rejection/mortality , Graft Rejection/pathology , Hematopoietic Stem Cells/cytology , Histocompatibility Testing , Immunosuppressive Agents/pharmacology , Postoperative Complications , Skin Transplantation/immunology , Spleen/pathology , Swine, Miniature , Tissue Donors , Transplantation Chimera
SELECTION OF CITATIONS
SEARCH DETAIL